Ubs Oconnor LLC Xencor Inc Transaction History

Ubs Oconnor LLC

$1.46 Billion
Q3 2024

A detailed history of Ubs Oconnor LLC transactions in Xencor Inc stock. As of the latest transaction made, Ubs Oconnor LLC holds 32,000 shares of XNCR stock, worth $661,440. This represents 0.04% of its overall portfolio holdings.

Number of Shares

32,000

Holding current value

$661,440

% of portfolio

0.04%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$15.7 - $21.65 $502,400 - $692,800	32,000 New	32,000 $643,000
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $627,033 - $978,388	23,502 New	23,502 $627,000

Others Institutions Holding XNCR

# of Institutions

216

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

Black Rock Inc. New York, NY

11.1M
Shares

$230 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

9.14M
Shares

$189 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

7.6M
Shares

$157 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.33M
Shares

$110 Million
4.65% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.93M
Shares

$81.2 Million
0.01% of portfolio

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.23B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account